Evolus (EOLS) News Today $10.51 -0.10 (-0.94%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 17, 2025 | businesswire.comEvolus: Still Bullish, But Business Faces Tricky Challenges In '25January 14, 2025 | seekingalpha.comEvolus (NASDAQ:EOLS) Reaches New 12-Month Low - Should You Sell?Evolus (NASDAQ:EOLS) Hits New 1-Year Low - What's Next?January 14, 2025 | marketbeat.comBarclays PLC Acquires 68,213 Shares of Evolus, Inc. (NASDAQ:EOLS)Barclays PLC increased its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 268.0% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 93,662 shares of the company's stock after buying an additional 68January 13, 2025 | marketbeat.comEvolus (NASDAQ:EOLS) Sets New 52-Week Low - Here's What HappenedEvolus (NASDAQ:EOLS) Sets New 1-Year Low - Time to Sell?January 8, 2025 | marketbeat.comBarclays PLC Has $1.52 Million Stake in Evolus, Inc. (NASDAQ:EOLS)Barclays PLC grew its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 268.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 93,662 shares of the company's stock after purchasing an additional 68,213 shareDecember 29, 2024 | marketbeat.comInsider Selling: Evolus, Inc. (NASDAQ:EOLS) CFO Sells 1,586 Shares of StockDecember 27, 2024 | insidertrades.comEvolus, Inc. (NASDAQ:EOLS) CFO Sells $17,208.10 in StockEvolus, Inc. (NASDAQ:EOLS - Get Free Report) CFO Sandra Beaver sold 1,586 shares of the firm's stock in a transaction dated Monday, December 23rd. The shares were sold at an average price of $10.85, for a total transaction of $17,208.10. Following the transaction, the chief financial officer now directly owns 146,916 shares in the company, valued at $1,594,038.60. The trade was a 1.07 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.December 26, 2024 | marketbeat.comEvolus, Inc. (NASDAQ:EOLS) Insider Sells $24,434.20 in StockEvolus, Inc. (NASDAQ:EOLS - Get Free Report) insider Rui Avelar sold 2,252 shares of the company's stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $10.85, for a total transaction of $24,434.20. Following the completion of the sale, the insider now directly owns 366,595 shares of the company's stock, valued at approximately $3,977,555.75. This represents a 0.61 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.December 26, 2024 | marketbeat.comEvolus, Inc. (NASDAQ:EOLS) Shares Sold by State Street CorpState Street Corp reduced its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 4.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,277,841 shares of the company's stock afterDecember 24, 2024 | marketbeat.comLord Abbett & CO. LLC Buys 188,685 Shares of Evolus, Inc. (NASDAQ:EOLS)Lord Abbett & CO. LLC raised its stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 23.4% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 995,449 shares of the company's stock after purchasing an additional 188,68December 16, 2024 | marketbeat.comEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 13, 2024 | businesswire.comCharles Schwab Investment Management Inc. Raises Stake in Evolus, Inc. (NASDAQ:EOLS)Charles Schwab Investment Management Inc. boosted its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 173.7% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 418,576 shares of the company's stock after acquiringDecember 12, 2024 | marketbeat.comWalleye Capital LLC Invests $3.44 Million in Evolus, Inc. (NASDAQ:EOLS)Walleye Capital LLC bought a new stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 212,209 shares of the company's stock, valued at approximately $3,43December 3, 2024 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Buys New Stake in Evolus, Inc. (NASDAQ:EOLS)Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 58,046 shares of the company's stock, valued at approximately $940,000November 28, 2024 | marketbeat.comEvolus, Inc. (NASDAQ:EOLS) Stake Decreased by Great Point Partners LLCGreat Point Partners LLC reduced its stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 52.3% in the third quarter, according to its most recent filing with the SEC. The fund owned 1,170,000 shares of the company's stock after selling 1,281,772 shares during the period. Evolus makes upNovember 27, 2024 | marketbeat.comEvolus (NASDAQ:EOLS) Trading Down 3.8% - Here's What HappenedEvolus (NASDAQ:EOLS) Trading Down 3.8% - Here's WhyNovember 22, 2024 | marketbeat.comEvolus’ Resilience and Growth Potential Amid Market Challenges: A Buy Recommendation by Uy EarNovember 20, 2024 | markets.businessinsider.comEvolus, Inc. (NASDAQ:EOLS) Short Interest Up 8.8% in OctoberEvolus, Inc. (NASDAQ:EOLS - Get Free Report) saw a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 5,430,000 shares, an increase of 8.8% from the October 15th total of 4,990,000 shares. Based on an average daily volume of 613,400 shares, the short-interest ratio is currently 8.9 days.November 18, 2024 | marketbeat.comGSA Capital Partners LLP Buys 93,176 Shares of Evolus, Inc. (NASDAQ:EOLS)GSA Capital Partners LLP grew its stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 335.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 120,964 shares of the company's stock after purchasingNovember 13, 2024 | marketbeat.comEarnings Update: Evolus, Inc. (NASDAQ:EOLS) Just Reported Its Third-Quarter Results And Analysts Are Updating Their ForecastsNovember 9, 2024 | finance.yahoo.comEvolus, Inc. (NASDAQ:EOLS) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | msn.comEvolus Inc (EOLS) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Market ChallengesNovember 7, 2024 | finance.yahoo.comEvolus Maintains Strong Growth Outlook Despite Earnings Miss: A Buy RecommendationNovember 7, 2024 | markets.businessinsider.comStifel Nicolaus Sticks to Its Buy Rating for Evolus (EOLS)November 7, 2024 | markets.businessinsider.comEvolus (NASDAQ:EOLS) Shares Gap Down on Disappointing EarningsEvolus (NASDAQ:EOLS) Shares Gap Down Following Weak EarningsNovember 7, 2024 | marketbeat.comHC Wainwright Reiterates Buy Rating for Evolus (NASDAQ:EOLS)HC Wainwright reissued a "buy" rating and issued a $27.00 price target on shares of Evolus in a research report on Thursday.November 7, 2024 | marketbeat.comEvolus, Inc. (EOLS) Q3 2024 Earnings Conference Call TranscriptNovember 6, 2024 | seekingalpha.comEvolus Reports Third Quarter 2024 ResultsNovember 6, 2024 | businesswire.comEvolus Gets EU Approval for Treatment of WrinklesNovember 2, 2024 | marketwatch.comEvolus (NASDAQ:EOLS) Earns Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $27.00 price target on shares of Evolus in a research report on Friday.November 1, 2024 | marketbeat.comEvolus to Participate in Stifel 2024 Healthcare ConferenceNovember 1, 2024 | businesswire.comEvolus, Inc. (NASDAQ:EOLS) Shares Acquired by Rice Hall James & Associates LLCRice Hall James & Associates LLC boosted its stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 6.3% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 904,900 shares of the company's stock after acquiring an additional 53,605 shares during the quarter.November 1, 2024 | marketbeat.comEvolus Rewards(TM) Patient Loyalty Program Surpasses 1 Million Enrolled ConsumersOctober 31, 2024 | stockhouse.comEvolus Announces EU Approval of Estyme® Injectable Hyaluronic Acid Gels Under New Medical Device RegulationOctober 31, 2024 | businesswire.comEvolus (EOLS) to Release Earnings on WednesdayEvolus (NASDAQ:EOLS) will be releasing earnings after the market closes on Wednesday, November 6, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=638774)October 30, 2024 | marketbeat.comEvolus rewards patient loyalty program surpasses 1M enrolled consumersOctober 30, 2024 | markets.businessinsider.comEvolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled ConsumersOctober 29, 2024 | finance.yahoo.comSemanteon Capital Management LP Makes New $912,000 Investment in Evolus, Inc. (NASDAQ:EOLS)Semanteon Capital Management LP acquired a new stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 56,313 shares of the company's stock, valued at approOctober 28, 2024 | marketbeat.comEvolus (NASDAQ:EOLS) Shares Down 6.2% - Here's WhyEvolus (NASDAQ:EOLS) Trading Down 6.2% - What's Next?October 17, 2024 | marketbeat.comSG Americas Securities LLC Buys Shares of 38,447 Evolus, Inc. (NASDAQ:EOLS)SG Americas Securities LLC bought a new stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 38,447 shares of the company's stock, valued at approximately $623,000. SOctober 15, 2024 | marketbeat.comEvolus (NASDAQ:EOLS) Hits New 1-Year High - Time to Buy?Evolus (NASDAQ:EOLS) Reaches New 52-Week High - Here's WhyOctober 14, 2024 | marketbeat.comEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 11, 2024 | businesswire.comEvolus' (NASDAQ:EOLS) investors will be pleased with their solid 119% return over the last three yearsOctober 11, 2024 | finance.yahoo.comEvolus Inc (EOLS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic AdvancementsOctober 9, 2024 | finance.yahoo.comEvolus, Inc. (NASDAQ:EOLS) Shares Sold by Millennium Management LLCMillennium Management LLC decreased its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 4.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 899,377 shares of the company's stock after selling 36,996 shares during the quarter. MillOctober 9, 2024 | marketbeat.comHealthcare of Ontario Pension Plan Trust Fund Buys Shares of 122,200 Evolus, Inc. (NASDAQ:EOLS)Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 122,200 shares of the company's stock, valued at apprOctober 8, 2024 | marketbeat.comEvolus, Inc. to Post Q3 2024 Earnings of ($0.12) Per Share, HC Wainwright Forecasts (NASDAQ:EOLS)Evolus, Inc. (NASDAQ:EOLS - Free Report) - Equities research analysts at HC Wainwright lowered their Q3 2024 earnings estimates for Evolus in a report released on Thursday, October 3rd. HC Wainwright analyst D. Tsao now expects that the company will post earnings per share of ($0.12) for the quarOctober 7, 2024 | marketbeat.comEvolus (NASDAQ:EOLS) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comEvolus (NASDAQ:EOLS) Trading Down 3.4% - Here's WhyEvolus (NASDAQ:EOLS) Trading Down 3.4% - Here's WhyOctober 4, 2024 | marketbeat.com Get Evolus News Delivered to You Automatically Sign up to receive the latest news and ratings for EOLS and its competitors with MarketBeat's FREE daily newsletter. Email Address EOLS Media Mentions By Week EOLS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EOLS News Sentiment▼0.530.46▲Average Medical News Sentiment EOLS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EOLS Articles This Week▼33▲EOLS Articles Average Week Get Evolus News Delivered to You Automatically Sign up to receive the latest news and ratings for EOLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Kymera Therapeutics News Today SpringWorks Therapeutics News Today Amneal Pharmaceuticals News Today Recursion Pharmaceuticals News Today Gemini Therapeutics News Today Edgewise Therapeutics News Today HUTCHMED News Today Arrowhead Pharmaceuticals News Today Mirum Pharmaceuticals News Today Harmony Biosciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EOLS) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EOLS Stock Alerts